CDC committee recommends RSV vaccine given to pregnant people to protect their babies

nbcnews.com Pregnant people should get an RSV vaccine at 32 to 36 weeks’ gestation in order to protect their newborns from RSV, according to an advisory committee to the Centers for…

U.S. CDC panel backs Pfizer’s maternal RSV vaccine to protect infants

theglobeandmail.com Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer’s PFE-N respiratory syncytial virus (RSV) vaccine for women in the middle of…

Biotech Stock Roundup: GSK’s Drug Approval, MRNA’s Vaccine News, PTCT & SPRY Down

247wallst.com It was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates. Among these, regulatory updates from GSK plc GSK and Moderna MRNA grabbed…

The UN admits member states ‘seem incapable of coming together’

aol.com Good morning, Peter Vanham here in Eclepens, Switzerland, filling in for Alan. The endless parade of United Nations meetings in New York this week could be forgiven if the…

Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival

investors.com Incyte stock tumbled to a nearly five-year low Monday after GSK gained FDA approval for a rival myelofibrosis treatment. The post Incyte Hits Five-Year Low After GSK Snags…

Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal

benzinga.com FDA has approved GSK plc's GSK Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis…

approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia

gsk.com Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy • Nearly all myelofibrosis patients are estimated to develop anaemia…

Johnson & Johnson unleashes power of the ampersand as it follows Sanofi, GSK in major rebrand

fiercepharma.com Sanofi tapped tech and GSK took out the scissors during their rebrands, but Johnson & Johnson is changing up its iconic logo and name for the “next chapter” in its corporate…

Covid, RSV and flu vaccines are now available

cnbc.com For the first time ever, vaccines for Covid, the flu and respiratory syncytial virus are available in the U.S. Public health officials are urging eligible Americans to take…

AstraZeneca succession sickness demands urgent fix

aol.com Can a CEO be worth $9 billion? That’s the question posed by the 4% fall in AstraZeneca’s shares following an article stating boss Pascal Soriot may soon resign. The company…

J&J, P&G, Walgreens sued after FDA panel ruling on cold medicine decongestant

reuters.com [1/2] The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New…

Databricks shakes VC money tree and $500M falls out

theregister.com Databricks has inhaled $500 million in funding – giving the data platform provider a nominal $43 billion valuation. In lieu of a much-delayed IPO, the company – initially…

Moderna Surges After Flu Shot Beats Out Widely Used Sanofi, GSK Vaccines

investors.com stock popped Wednesday after the company said its experimental flu shot outperformed broadly used vaccines from Sanofi and GSK. The company pitted its messenger-RNA-based…

Moderna says flu vaccine showed promising results in phase three trial, paving path to approval

cnbc.com Moderna on Wednesday said its experimental mRNA-based flu vaccine produced a stronger immune response against four strains of the virus than a currently available flu…

Moderna says mRNA flu shot generates better immune response in study than currently available vaccine

cnn.com Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently…

Moderna aims to prove it’s ‘more than a COVID company’

marketwatch.com As it looks to expand its horizons beyond COVID-19 vaccines, Moderna Inc. MRNA, on Wednesday released positive results from a late-stage trial of an mRNA flu vaccine and…

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch

benzinga.com According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by…